7Baggers

Clene Inc
(NASDAQ:CLNN) 

CLNN stock logo

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean surfaced nanotechnology (CSN) therapeutics. The company has a nanotechnology drug suspension; and engages in the development and commercialization of dietary supplements. ...

Founded: 2013
CEO: Rob Etherington  
Sector:
Industry:

Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.94
H 3.04
L 2.69
C 2.69
V 34,161
10EMA 2.69
20EMA 2.69
60EMA 2.69
120EMA 2.69
250EMA 2.69
CLNN - Daily